WARREN, N.J., July 26, 2017 /PRNewswire/ -- Roka
Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company
focused on providing advanced testing solutions for the detection
of foodborne pathogens will host and present a free, informative
webinar titled "Game of Zones: A Practical Guide to Listeria
Monitoring and Detection" with guest speaker Dr. Virginia Deibel from Covance.
The webcast topics will include:
- Demonstrating Listeria control through
monitoring – a case study
- Fuzzy attributes of regulatory guidance documents
- Environmental Control Programs- what they are and what they are
not
- When is Listeria reasonably likely to
occur?
- Data demonstrating how new pathogen testing technology is
surpassing the traditional culture
This free webcast will take place live on Thursday,
August 3rd at 2:00 PM EDT.
Dr. Virginia Deibel, Director of Microbiology at Covance,
will be presenting "Taking the Fuzzy out of Logic" which will
provide an example driven guide that can serve as a template for
food processors in the development and execution of Listeria
monitoring programs.
The webcast will also feature Dr. Evan
Chaney, Director of Customer Applications and Microbiology
at Roka Bioscience who will present "Trusting the Method",
highlighting recent data that supports adoption of advanced,
molecular diagnostics in food safety as they surpass the
traditional culture based gold standards.
To register for this free informative podcast click here:
About Roka Bioscience
Roka Bioscience, Inc. is
a molecular diagnostics company focused on developing and
commercializing advanced testing solutions for the food safety
testing market. Our Atlas® Detection Assays
incorporate our advanced molecular technologies and are performed
on our "sample-in, result out" Atlas System that automates all
aspects of molecular diagnostic testing on a single, integrated
platform. The Atlas System and Detection Assays are designed to
provide our customers with accurate and rapid test results with
reduced labor costs and improved laboratory efficiencies. For more
information, visit https://www.rokabio.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 and the Private
Securities Litigation Reform Act, as amended (the "Exchange Act"),
including those related to our planned service offerings. These
forward-looking statements are based on current expectations,
estimates, forecasts and projections about the industry and markets
in which we operate and management's current beliefs and
assumptions. Any statements contained herein (including, without
limitation, statements to the effect that we "believe", "expect",
"anticipate", "plan" and similar expressions) that are not
statements of historical fact should be considered forward-looking
statements. These statements relate to future events or our
financial performance and involve known and unknown risks,
uncertainties and other factors that could cause our actual
results, levels of activity, performance or achievement to differ
materially from those expressed or implied by these forward looking
statements. There are a number of important factors that could
cause actual results to differ materially from those indicated by
such forward-looking statements. Such factors include those set
forth in the company's filings with the Securities and Exchange
Commission. We expressly disclaim any obligation to update any
forward-looking statements, except as may be required by law.
Given these uncertainties, you should not place undue reliance on
these forward-looking statements. These forward-looking statements
represent our estimates and assumptions only as of the date of this
press release and, except as required by law, we undertake no
obligation to update or review publicly any forward-looking
statements, whether as a result of new information, future events
or otherwise after the date of this press release.
Investor or Media related inquiries please contact:
Investor Contact:
Roka Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)
View original
content:http://www.prnewswire.com/news-releases/roka-bioscience-to-co-present-industry-webinar---game-of-zones-a-practical-guide-to-listeria-monitoring-and-detection-300494280.html
SOURCE Roka Bioscience, Inc.